👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
All content for Inside Lyme Podcast with Dr. Daniel Cameron is the property of Dr. Daniel Cameron and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
Children Under 18 Were Left Out of NIH Lyme Disease Trials
Inside Lyme Podcast with Dr. Daniel Cameron
3 minutes
2 months ago
Children Under 18 Were Left Out of NIH Lyme Disease Trials
“Has your family faced challenges with Lyme disease treatment for kids? Share your story in the comments—because until children are included in research, parents’ voices are one of the most powerful tools we have. . . No NIH-funded Lyme treatment trials have included children under 18. Yet kids often present differently than adults—showing fatigue, mood or school changes, rather than joint pain. Their developing immune and nervous systems also process infection and medication uniquely. ...
Inside Lyme Podcast with Dr. Daniel Cameron
👉 Have you faced delays in Lyme disease treatment? Comment below. Physician reluctance in Lyme disease treatment often stems from liability concerns, conflicting guidelines, limited training, and insurance pressures. While hesitation may protect doctors professionally, it can leave patients untreated, leading to infection spread, long-term complications, and emotional trauma. The risks of treatment — side effects, gut imbalance, or temporary Herxheimer reactions — are usually short-term and...
